Abstract
Background:Immune response in patients with immune-mediated inflammatory diseases (IMID) is compromised. The patients have more frequent and severe infections, including COVID-19, and reduced efficacy of vaccinations. As SARS-CoV2 vaccine trials...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have